SHARE
Preventive Vaccines Market

Preventive Vaccines - Global Market Outlook (2018-2027)

4.1 (47 reviews)
Published: April 2020 ID: SMRC19023
4.1 (47 reviews)
Published: April 2020 ID: SMRC19023

This report covers the impact of COVID-19 on this global market

According to Stratistics MRC, the Global Preventive Vaccines market is accounted for $40.80 billion in 2018 and is expected to reach $94.64 billion by 2027 growing at a CAGR of 9.8% during the forecast period. Some of the key factors propelling the market growth include increased funding from government and international organizations, growing prevalence of infectious diseases, rise in investments, initiatives by NGO’s, and innovative technology in vaccine development. However, high cost of vaccine development is restraining the market growth.

Preventative vaccine is administered to a person who is free of the targeted infection, in order to support the body’s immune system against future infections. These vaccines consist of attenuated or killed microbes, or microbial DNA. When administered, the immune system triggers a response that produces antibodies. Various infectious diseases are considered to be the world’s leading causes of death. Scientists of various countries are performing various researches, building laboratories in underdeveloped countries, sharing information, and creating surveillance networks globally in order to control the disease spread through preventive vaccination.

By vaccine type, live/attenuated vaccines contain weakened versions of living microbes, making them ineffective to cause diseases. These vaccines produce a similar, yet weakened reaction, compared to that of natural infections. These vaccines need to be refrigerated to stay potent. In addition, Live/attenuated vaccines for certain viruses are relatively easy to create. Vaccines against measles, mumps, and chickenpox, among others, are designed using this method. Pertaining to the ease of manufacturing, and the ability to generate strong immune responses to the market for live/attenuated vaccines, a steady growth rate is expected during the forecast period.

On the basis of geography, North America is expected to have considerable market growth during the forecast period. In the United States, the Centers for Disease Control and Prevention's (CDC) Advisory Committee for Immunization Practices (ACIP) routinely publishes recommendations for adult and childhood vaccination. The United States has one of the leading healthcare systems in the world and the vaccination coverage, in terms of vaccine inclusion, is at par with the WHO guidelines.

Some of the key players in preventive vaccines market include AstraZeneca PLC, Johnson & Johnson, CSL Limited, Bavarian Nordic, GlaxoSmithKline PLC, MedImmune LLC, Merck and Company, Sanofi Pasteur, Takeda Pharmaceutical Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Daiichi Sankyo Co. Ltd., Emergent BioSolutions, Inc., Novartis AG, and Pfizer, Inc.
 
Disease Types Covered:
• Influenza
• Measles, Mumps, and Rubella (MMR)
• Poliovirus
• Hepatitis
• Pneumococcal
• HIB
• Varicella
• Zoster
• Cervical Cancer
• Human Papilloma Virus

Vaccine Types Covered:
• Toxoid Vaccines
• Subunit Vaccines
• Inactivated Vaccines
• Live/Attenuated Vaccines
• DNA Vaccines
• Conjugate Vaccines
• Recombinant Vector Vaccines

End Users Covered:
• Adult Vaccines
• Pediatric Vaccines

Product Types Covered:
• Nasal Spray
• Intramuscular Injection
• Intradermal Shot

Applications Covered:
• Clinic
• Hospital

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK 
o Spain
o Rest of Europe      
• Asia Pacific
o Japan       
o China       
o India       
o Australia       
o New Zealand      
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis, etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary     
      
2 Preface  
   
 2.1 Abstract    
 2.2 Stake Holders    
 2.3 Research Scope    
 2.4 Research Methodology    
  2.4.1 Data Mining   
  2.4.2 Data Analysis   
  2.4.3 Data Validation   
  2.4.4 Research Approach   
 2.5 Research Sources    
  2.5.1 Primary Research Sources   
  2.5.2 Secondary Research Sources   
  2.5.3 Assumptions   
      
3 Market Trend Analysis     
 3.1 Introduction    
 3.2 Drivers    
 3.3 Restraints    
 3.4 Opportunities    
 3.5 Threats    
 3.6 End User Analysis    
 3.7 Product Analysis    
 3.8 Application Analysis    
 3.9 Emerging Markets    
 3.10 Impact of Covid-19    
      
4 Porters Five Force Analysis     

 4.1 Bargaining power of suppliers    
 4.2 Bargaining power of buyers    
 4.3 Threat of substitutes    
 4.4 Threat of new entrants    
 4.5 Competitive rivalry    
      
5 Global Preventive Vaccines Market, By Disease Type     
 5.1 Introduction    
 5.2 Influenza     
 5.3 Measles, Mumps, and Rubella (MMR)    
 5.4 Poliovirus    
 5.5 Hepatitis    
 5.6 Pneumococcal    
 5.7 HIB    
 5.8 Varicella    
 5.9 Zoster    
 5.10 Cervical Cancer    
 5.11 Human Papilloma Virus    
      
6 Global Preventive Vaccines Market, By Vaccine Type     
 6.1 Introduction    
 6.2 Toxoid Vaccines    
 6.3 Subunit Vaccines    
 6.4 Inactivated Vaccines    
 6.5 Live/Attenuated Vaccines    
 6.6 DNA Vaccines    
 6.7 Conjugate Vaccines    
 6.8 Recombinant Vector Vaccines    
      
7 Global Preventive Vaccines Market, By End User     

 7.1 Introduction        
 7.2 Adult Vaccines    
 7.3 Pediatric Vaccines    
      
8 Global Preventive Vaccines Market, By Product Type     

 8.1 Introduction    
 8.2 Nasal Spray    
 8.3 Intramuscular Injection    
 8.4 Intradermal Shot    
      
9 Global Preventive Vaccines Market, By Application     
 9.1 Introduction    
 9.2 Clinic    
 9.3 Hospital    
      
10 Global Preventive Vaccines Market, By Geography     
 
 10.1 Introduction    
 10.2 North America    
  10.2.1 US   
  10.2.2 Canada   
  10.2.3 Mexico   
 10.3 Europe    
  10.3.1 Germany   
  10.3.2 UK   
  10.3.3 Italy   
  10.3.4 France   
  10.3.5 Spain   
  10.3.6 Rest of Europe   
 10.4 Asia Pacific    
  10.4.1 Japan   
  10.4.2 China   
  10.4.3 India   
  10.4.4 Australia   
  10.4.5 New Zealand   
  10.4.6 South Korea   
  10.4.7 Rest of Asia Pacific   
 10.5 South America    
  10.5.1 Argentina   
  10.5.2 Brazil   
  10.5.3 Chile   
  10.5.4 Rest of South America   
 10.6 Middle East & Africa    
  10.6.1 Saudi Arabia   
  10.6.2 UAE   
  10.6.3 Qatar   
  10.6.4 South Africa   
  10.6.5 Rest of Middle East & Africa   
      
11 Key Developments     
 11.1 Agreements, Partnerships, Collaborations and Joint Ventures    
 11.2 Acquisitions & Mergers    
 11.3 New Product Launch    
 11.4 Expansions    
 11.5 Other Key Strategies    
      
12 Company Profiling     
 12.1 AstraZeneca PLC    
 12.2 Johnson & Johnson    
 12.3 CSL Limited    
 12.4 Bavarian Nordic    
 12.5 GlaxoSmithKline PLC    
 12.6 MedImmune LLC    
 12.7 Merck and Company    
 12.8 Sanofi Pasteur    
 12.9 Takeda Pharmaceutical Co. Ltd.    
 12.10 Mitsubishi Tanabe Pharma Corporation    
 12.11 Daiichi Sankyo Co. Ltd.    
 12.12 Emergent BioSolutions, Inc.    
 12.13 Novartis AG    
 12.14 Pfizer, Inc   


List of Tables      
1 Global Preventive Vaccines Market Outlook, By Region (2017-2027) ($MN)     
2 Global Preventive Vaccines Market Outlook, By Disease Type (2017-2027) ($MN)     
3 Global Preventive Vaccines Market Outlook, By Influenza (2017-2027) ($MN)     
4 Global Preventive Vaccines Market Outlook, By Measles, Mumps, and Rubella (MMR) (2017-2027) ($MN)      
5 Global Preventive Vaccines Market Outlook, By Poliovirus (2017-2027) ($MN)     
6 Global Preventive Vaccines Market Outlook, By Hepatitis (2017-2027) ($MN)     
7 Global Preventive Vaccines Market Outlook, By Pneumococcal (2017-2027) ($MN)     
8 Global Preventive Vaccines Market Outlook, By HIB (2017-2027) ($MN)     
9 Global Preventive Vaccines Market Outlook, By Varicella (2017-2027) ($MN)     
10 Global Preventive Vaccines Market Outlook, By Zoster (2017-2027) ($MN)     
11 Global Preventive Vaccines Market Outlook, By Cervical Cancer (2017-2027) ($MN)     
12 Global Preventive Vaccines Market Outlook, By Human Papilloma Virus (2017-2027) ($MN)     
13 Global Preventive Vaccines Market Outlook, By Vaccine Type (2017-2027) ($MN)     
14 Global Preventive Vaccines Market Outlook, By Toxoid Vaccines (2017-2027) ($MN)     
15 Global Preventive Vaccines Market Outlook, By Subunit Vaccines (2017-2027) ($MN)     
16 Global Preventive Vaccines Market Outlook, By Inactivated Vaccines (2017-2027) ($MN)     
17 Global Preventive Vaccines Market Outlook, By Live/Attenuated Vaccines (2017-2027) ($MN)     
18 Global Preventive Vaccines Market Outlook, By DNA Vaccines (2017-2027) ($MN)     
19 Global Preventive Vaccines Market Outlook, By Conjugate Vaccines (2017-2027) ($MN)     
20 Global Preventive Vaccines Market Outlook, By Recombinant Vector Vaccines (2017-2027) ($MN)     
21 Global Preventive Vaccines Market Outlook, By End User (2017-2027) ($MN)     
22 Global Preventive Vaccines Market Outlook, By Adult Vaccines (2017-2027) ($MN)     
23 Global Preventive Vaccines Market Outlook, By Pediatric Vaccines (2017-2027) ($MN)     
24 Global Preventive Vaccines Market Outlook, By Product Type (2017-2027) ($MN)     
25 Global Preventive Vaccines Market Outlook, By Nasal Spray (2017-2027) ($MN)     
26 Global Preventive Vaccines Market Outlook, By Intramuscular Injection (2017-2027) ($MN)     
27 Global Preventive Vaccines Market Outlook, By Intradermal Shot (2017-2027) ($MN)     
28 Global Preventive Vaccines Market Outlook, By Application (2017-2027) ($MN)     
29 Global Preventive Vaccines Market Outlook, By Clinic (2017-2027) ($MN)     
30 Global Preventive Vaccines Market Outlook, By Hospital (2017-2027) ($MN)     
      
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.      

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Allows one person to have access to the ordered product.The ordered product cannot be distributed to anyone else.
Allows the ordered product to be shared among a maximum of 5 people within your organisation.
Allows the product to be shared among all employees of your organisation at one particular location.
Allows the product to be shared among all employees of your organisation regardless of their geographical location.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials